Community-Acquired Pneumonia Hospitalization among Children with Neurologic Disorders

Alexander J Millman1, Lyn Finelli2, Anna M Bramley2

  • 1Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA.

Insights

Children with neurologic disorders hospitalized for community-acquired pneumonia (CAP) were more likely to need intensive care. Pathogen detection was less frequent in these children compared to those without neurologic conditions.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neurology

Background:

  • Community-acquired pneumonia (CAP) presents unique challenges in children with underlying health conditions.
  • Neurologic disorders can significantly impact the clinical course and outcomes of pediatric CAP.
  • Understanding these differences is crucial for optimizing patient care and resource allocation.

Purpose of the Study:

  • To compare the clinical characteristics, outcomes, and causes of CAP in children with and without neurologic disorders.
  • To identify specific risk factors and clinical trajectories associated with CAP in children with neurologic conditions.

Main Methods:

  • Retrospective analysis of 2358 children hospitalized with radiographically confirmed CAP across three US children's hospitals (January 2010-June 2012).
  • Categorization of patients into three groups: those with neurologic disorders, those with non-neurologic underlying conditions only, and those with no underlying conditions.
  • Utilized bivariate, age-stratified, and multivariate logistic regression to compare epidemiology, etiology, and clinical outcomes.

Main Results:

  • Children with neurologic disorders were older and had higher rates of intensive care unit (ICU) admission compared to other groups.
  • Mechanical ventilation rates were similar across groups, but pathogen detection was less frequent in children with neurologic disorders.
  • Multivariate analysis indicated that neurologic disorders were associated with ICU admission in children aged 2 years and older.

Conclusions:

  • Pediatric patients with neurologic disorders hospitalized for CAP exhibit distinct clinical patterns, including increased ICU admission rates.
  • The lower detection rate of pathogens in children with neurologic disorders warrants further investigation into diagnostic and treatment strategies.
  • Neurologic disorders are a significant factor influencing CAP severity and outcomes in hospitalized children.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.0K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
13